The University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
Location status: Recruiting
NCT Number: NCT04234971
The purpose of this trial is to evaluate if the use of Bone Morphogenic Protein(BMP)/Demineralized Bone Matrix (DBM) versus the use of autologous Iliac Crest Bone Graft (ICBG) will result in an increase in total cost effectiveness for patients undergoing alveolar bone graft (ABG) for Cleft Lip and Palate (CLP) and to see if patients who are treated with DBM/BMP will have reduced post-operative pain scores,reduced operative times,and similar rates of bone healing compared to conventional ICBG.
Interested in participating?
Request Info6 year–15 year
All sexes
Interventional
Phase 4
Houston, Texas, 77030, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All patients will undergo a standard procedure for exposure of the cleft alveolar defect and closure of all oronasal fistulae. After induction of general anesthesia, the patient will be intubated with an oral ray tube and prepped and draped in sterile fashion. Pre-operative antibiotics will be given to cover oral flora (i.e. Unasyn or clindamycin if penicillin allergy exists). The intra-oral space will be exposed and the nasal floor and palatal mucosa will be primarily closed to create a water-tight space for the graft. The integrity of the nasal floor mucosa will be tested using methylene blue dye. Following closure of the fistula, the alveolar bone graft will be performed. For the treatment group, 10cc of crushed DBM will be mixed with the micro-sized sponge of rh-BMP-2 (Infuse Bone Graft, Medronic, Minneapolis, MN). The sponge and DBM will then be packed into the defect to completely fill the bony space (FIGURE 3). The anterior mucosa will then be closed.
The patient will be induced with anesthesia, prepped, and draped. The intra-oral space will be exposed and the nasal floor and palatal mucosa will be primarily closed to create a water-tight space for the graft. The integrity of the nasal floor mucosa will be tested using methylene blue dye. Following closure of the fistula, the alveolar bone graft will be performed.In the control group, the ICBG will be harvested percutaneously using the Accumed bone graft harvesting system. Briefly, an incision will be made in iliac crest and drill bit inserted. Multiple passes of the drill be used to harvest as much autograft bone as possible from the cancellous region of the iliac crest.Following harvest, fibrin glue will be instilled for hemostasis and a Ropivicaine On-Q pain pump inserted for post-operative pain control. The harvest bone graft will be packed into the alveolar defect in a similar fashion and the mucosa closed anteriorly.
Time frame: One year post graft
Health system costs will be reported as the total sum of all costs including incremental surgeon time costs, hospital costs, revision costs, and additional outpatient costs for clinic or ER visits. Bone graft success be defined as no need for a repeat bone graft, as well as by assessment by blinded orthodontist evaluations of the Post op Cone beam computed tomography(CBCT).
Time frame: 3 months post graft
Graft success as indicated by number of patients that did not have exposure of graft as assessed by post op CBCT
Time frame: 3 months post graft
Graft success as indicated by number of patients that had no graft infection as assessed by post op CBCT
Time frame: 3 months post graft
Graft success as indicated by number of patients that had no recurrence of oronasal fistula as assessed by post op CBCT
Time frame: 3 months post graft
Graft success as indicated by number of patients that had no no need for repeat bone graft as assessed by post op CBCT
Time frame: 1 day
Total time for operation
Time frame: 1 day
total time of anesthesia
Time frame: 1 week post operatively
Change in pain as assessed by the numeric Rating Scale(NRS) for pain. The NRS total score ranges form 0(no hurt) to 10(hurts worst)
Time frame: 1 week post operatively
Total dose of post-operative narcotics used
Time frame: 3 months
Number of patients with the post operative complication fever
Time frame: 3 months
Number of patients with the post operative complication drainage from donor site or alveolar site
Time frame: 3 months.
Number of patients with the post operative complication ER or primary care visits
Contact information is provided by the study sponsor or research team.
The University of Texas Health Science Center, Houston
Other
Cost Effectiveness in Alveolar Bone Grafting in Patients With Cleft Lip and Palate: A Randomized Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03065686
Cleft Lip, Cleft Lip and Palate
Amiens, France
View Trial DetailsNCT04771156
Cleft Lip, Cleft Lip and Palate
Houston, Texas, United States
View Trial DetailsNCT07340008
Alveolar Ridge Defect, Cleft Lip
Ljubljana, Slovenia
View Trial DetailsNCT04422847
Cleft Lip, Cleft Lip and Palate
Brno, Jihomoravská Kraj, Czechia
View Trial Details